"At MHP Radiation Oncology Institute, part of Genesiscare network, we offer multidisciplinary personalized cancer treatments based on individual patient needs. From the latest techniques and cutting-edge technologies to our highly skilled team of physicians, we provide world-class cancer care close to home."

During the past decade, GenesisCare USA - Clarkston conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 4 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 15 clinical trials started and 4 clinical trials were completed. i.e. 26.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "GenesisCare USA - Clarkston" #1 sponsor was "NRG Oncology" with 13 trials, followed by "National Cancer Institute (NCI)" with 8 trials sponsored, "Radiation Therapy Oncology Group" with 2 trials sponsored, "Alliance for Clinical Trials in Oncology" with 1 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "GenesisCare USA - Clarkston" #1 collaborator was "National Cancer Institute (NCI)" with 18 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Radiation Therapy Oncology Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "GenesisCare USA - Clarkston" are "Prostate Adenocarcinoma" (5 trials), "Stage II Lung Cancer AJCC v8" (3 trials), "Stage II Prostate Adenocarcinoma" (3 trials), "Stage III Lung Cancer AJCC v8" (3 trials) and "Stage III Prostate Adenocarcinoma" (3 trials). Many other conditions were trialed in "GenesisCare USA - Clarkston" in a lesser frequency.

Most popular intervention types in "GenesisCare USA - Clarkston" are "Radiation" (21 trials), "Drug" (20 trials), "Other" (12 trials), "Procedure" (7 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (9 trials), "Radiation Therapy" (7 trials), "Bicalutamide" (5 trials), "Cisplatin" (5 trials) and "Atezolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "GenesisCare USA - Clarkston" are 14 trials for "All" genders, 11 trials for "Male" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "GenesisCare USA - Clarkston". undefined are not yet recruiting, 12 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in GenesisCare USA - Clarkston, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in GenesisCare USA - Clarkston, 2 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

GenesisCare USA - Clarkston has several departments that took part in Clinical trials: "Commonwealth Cancer Center-Corbin" - 148 trials, "Sampson Radiation Oncology" - 25 trials